Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Hodgkin Disease × Gemcitabine × Clear all

Phase

Status

Completed 27 Terminated 7 Recruiting 6 Unknown 4 Withdrawn 2 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 41 Urinary Bladder Neoplasms 18 Carcinoma, Non-Small-Cell Lung 15 Ovarian Neoplasms 11 Neoplasm Metastasis 11 Triple Negative Breast Neoplasms 10 Nasopharyngeal Carcinoma 10 Breast Neoplasms 9 Lymphoma, Large B-Cell, Diffuse 8 Lung Neoplasms 8 Fallopian Tube Neoplasms 8 Carcinoma, Transitional Cell 7 Neoplasms 6 Cholangiocarcinoma 6 Biliary Tract Neoplasms 6 Recurrence 5 Non-Muscle Invasive Bladder Neoplasms 5 Gallbladder Neoplasms 5 Colorectal Neoplasms 5 Urothelial Cancer 3 Urethral Neoplasms 3 Stomach Neoplasms 3 Melanoma 3 Colonic Neoplasms 3 Carcinoma 3 Ureteral Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Nasopharyngeal Neoplasms 2

Interventions

Doxorubicin 10 Cyclophosphamide 10 Vinblastine 9 Nivolumab 9 Dacarbazine 8 Brentuximab Vedotin 8 fludarabine phosphate 6 fludarabine 6 Radiotherapy 6 Etoposide 6 Bleomycin 6 pembrolizumab 5 Melphalan 5 Whole-Body Irradiation 4 Vincristine 4 Prednisone 4 Peripheral Blood Stem Cell Transplantation 4 Mycophenolic Acid 4 Tacrolimus 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Busulfan 3 Thiotepa 2 Sirolimus 2 Radiation 2 Procarbazine 2 Prednisolone 2 Mechlorethamine 2 Carmustine 2 Bendamustine Hydrochloride 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05502250 2026-03-06

HOVON164HL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 2 Active not recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡